Conferences - Results from #10180

EAU 2016 Radium-223 (Ra-223) re-treatment (re-tx): Experience from an international, multicenter, prospective study in patients (pts) with castration-resistant prostate cancer and bone metastases (mCRPC) - Poster Session Highlights March 15, 2016

EAU 2016 Randomized controlled trial of ultra mini percutaneous nephrolithotomy versus retrograde intrarenal surgery in the treatment of 10-30mm calculi - Session Highlights March 15, 2016

EAU 2016 Percutaneous nephrolithotomy under X-ray control and totally ultrasound-guided percutaneous nephrolithotomy: The outcome comparison - Session Highlights March 14, 2016

EAU 2016 Feasibility of supracostal access in supine percutaneous renal surgery - Session Highlights March 14, 2016

EAU 2016: Do we really need to perform partial nephrectomy with zero ischemia? - Session Highlights March 14, 2016

EAU 2016 Survival Outcomes in Octogenarian and nonagenarian patients treated with first-line androgen deprivation therapy for localized prostate cancer. - Session Highlights March 14, 2016

EAU 2016 Long-term quality of life outcomes after active surveillance or curative treatment for prostate cancer - Session Highlights March 14, 2016

EAU 2016 Comparative analysis of immediate vs delayed prostatectomy in prostate cancer patients eligible for active surveillance. - Session Highlights March 14, 2016

EAU 2016 Predictive factors SIB Score - Poster Session Highlights March 14, 2016

EAU 2016 Phase III intermittent vs continuous ADT - Poster Session Highlights March 14, 2016

EAU 2016 Immunotherapy for prostate cancer: What the future holds - Session Highlights March 14, 2016

EAU 2016 Prostate Cancer—Management of atypical histologies - Session Highlights March 14, 2016

EAU 2016 Immunotherapy for bladder cancer – benefits for all patients? - Session Highlights March 14, 2016

EAU 2016 Peri-operative chemotherapy for bladder cancer: Urological aspects - Session Highlights March 14, 2016

EAU 2016 Peri-operative chemotherapy for bladder cancer: Oncological aspects - Session Highlights March 14, 2016

EAU 2016 Does a high quality TURB make a re-resection redundant - Session Highlights March 14, 2016

EAU 2016 Carcinoma In Situ: Low incidence or underdetection? - Session Highlights March 14, 2016

EAU 2016 Greater Survival Benefit Shown in Men with Early and Less Aggressive Metastatic Castration-Resistant Prostate Cancer Treated with ZYTIGA® Plus Prednisone March 14, 2016

EAU 2016 Robotic versus laparoscopic approach for retroperitoneal partial nephrectomy - Session Highlights March 14, 2016

EAU 2016 Robotic vs open partial nephrectomy for patients with pre-existing chronic kidney disease - Session Highlights March 13, 2016

Page 510 of 594